Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

NERV — Minerva Neurosciences, Inc. SEC Filings | FilingIndex

NERVNasdaq

Minerva Neurosciences, Inc.

Pharmaceutical Preparations · MA · CIK 1598646

Minerva Neurosciences, Inc. develops and seeks regulatory approval for roluperidone and other potential product candidates

+ Watch View on EDGAR ↗

$210M

Market cap

$5.55

Last close

+2.2%

1D

+27.6%

5D

221K

Volume

Price · last 40 sessions-12.3%

May 4L $4.11 · H $6.33Jun 30

234

Total filings

Jun 4, 2026

Last filing

12/31

Fiscal year end

All 8-K · 127 10-Q · 36 SC 13G · 13 DEF 14A · 12 10-K · 12 DEFA14A · 11 10-K/A · 5 424B5 · 5

10-Q10-QMay 5, 2026 10-Q10-QNov 5, 2025 10-Q10-QAug 14, 2025 10-Q10-QMay 13, 2025 10-Q10-QNov 5, 2024 10-Q

Similar companies

Comparable business profile · signals at a glance

ANROAlto Neuroscience, Inc.$753.5M-6.0%ACIUAC Immune SA$235.1M-10.5%BYSIBeyondSpring Inc.$64.6M-2.2%ASRTAssertio Holdings, Inc.$151.7M+0.1%BLTEBELITE BIO, INC

10-Q

Aug 6, 2024

10-Q10-QMay 1, 2024

10-Q10-QNov 7, 2023

10-Q10-QAug 1, 2023

10-Q10-QMay 15, 2023

10-Q10-QNov 9, 2022

10-Q10-QAug 9, 2022

10-Q10-QMay 4, 2022

10-Q10-QNov 8, 2021

10-Q10-QAug 2, 2021

10-Q10-QMay 12, 2021

10-Q10-QNov 2, 2020

10-Q10-QAug 3, 2020

10-Q10-QMay 4, 2020

10-Q10-QNov 4, 2019

10-Q10-QAug 5, 2019

10-Q10-QMay 6, 2019

10-Q10-QNov 5, 2018

10-Q10-QAug 2, 2018

10-Q10-QMay 3, 2018

10-Q10-QNov 6, 2017

10-Q10-QAug 3, 2017

10-QFORM 10-QMay 4, 2017

10-QFORM 10-QNov 3, 2016

10-QFORM 10-QAug 4, 2016

10-Q10-QMay 3, 2016

10-Q10-QNov 5, 2015

10-Q10-QAug 5, 2015

10-Q10-QMay 7, 2015

10-Q10-QNov 6, 2014

10-Q10-QAug 7, 2014

$5.5B

-0.4%

ACRSAclaris Therapeutics, Inc.$603.3M+5.4%